Goldman Sachs’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $4.97M | Sell |
|
|||||
|
2022
Q4 | $7.21M | Sell |
|
|||||
|
2022
Q3 | $8.94M | Buy |
|
|||||
|
2022
Q2 | $3.87M | Buy |
|
|||||
|
2022
Q1 | $1.63M | Buy |
|
|||||
|
2021
Q4 | $152K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $104K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $185K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $21K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $326K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $8K | Sell |
|
|||||
|
2018
Q3 | $35K | Sell |
|
|||||
|
2018
Q2 | $412K | Sell |
|
|||||
|
2018
Q1 | $1.65M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $77K | Sell |
|
|||||
|
2017
Q1 | $216K | Sell |
|
|||||
|
2016
Q4 | $464K | Sell |
|
|||||
|
2016
Q3 | $515K | Sell |
|
|||||
|
2016
Q2 | $507K | Buy |
|
|||||
|
2016
Q1 | $64K | Sell |
|
|||||
|
2015
Q4 | $398K | Buy |
|
|||||
|
2015
Q3 | $396K | Sell |
|
|||||
|
2015
Q2 | $979K | Buy |
|
|||||
|
2015
Q1 | $638K | Sell |
|
|||||
|
2014
Q4 | $1.39M | Buy |
|
|||||
|
2014
Q3 | $1.09M | Buy |
|
|||||
|
2014
Q2 | $1.13M | Sell |
|
|||||
|
2014
Q1 | $1.57M | Sell |
|
|||||
|
2013
Q4 | $1.65M | Buy |
|
|||||
|
2013
Q3 | $58K | Buy |
|
|||||
|
2013
Q2 | $31K | Buy |
|